Skip to main content
SpringerLink
Log in

Local immunity and the uterine cervix: Implications for cancer-associated viruses

  • Review
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Studies of cervical secretions as well as cells composing the endocervix have provided evidence for a functional and potentially important immunological system in the mucosa of that organ. The availability of the tools of cell biology as well as three agents that may be used as probes to infect cervical mucosa experimentally has made possible a detailed approach to define the structural and functional characteristics of local cervical immunity. A long-term goal of these studies is to determine how the cervical immune response may be regulated to reduce local viral replication and virus-associated diseases. With Langerhans cells for antigen presentation, cervical immune responses generally remain detectable for more than 30 days, are predominantly of the IgA isotype, can be influenced by estrogen or progesterone, and are best elicited by local rather than systemic exposure to antigen. Cervical immune responses to the human papillomaviruses (HPV) are of particular importance in this regard because this virus is associated with cervical neoplasia. While responses in serum to HPV-16 proteins L1, E4, and E7 has been found in up to 78% of persons with HPV-associated cervical neoplasms, data showing that a local response of comparable frequency consistently occurs have yet to be confirmed. The current status of local HPV-16-specific immunoglobulin as a potentially useful indicator of HPV-16-related infection or pre-cancer is controversial, and is confounded by several potentially important factors, including patient age, estrogen/progesterone level, smoking status, and sample admixture with serum immunoglobulin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Reference deleted

  2. Becker J, Behem J, Loning TH, Reichart P, Geerlings H (1985) Quantitative analysis of immunocompetent cells in human normal oral and uterine cervical mucosa, oral papillomavirus and leukoplakias. Arch Oral Biol 30: 257–264

    PubMed  Google Scholar 

  3. Boshart M, Gissman L, Ikenberg H, Kleinheinz A, Scheurlen W, Zur Hausen H (1984) A new type of papillomavirus DNA and its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3: 1151–1157

    PubMed  Google Scholar 

  4. Broker TR, Chow MT, Chin MT, Rhodes CR, Wolinsky SM, Whitbech H, Stoler M (1990) A molecular portrait of human papillomavirus carcinogenesis. In: Cancer cells. Cold Spring Harbor Laboratory, pp 197–207

  5. Reference deleted

  6. Chipperfield EJ, Evans BA (1972) The influence of local infection on immunoglobulin formation in the human endocervix. Clin Exp Immunol 11: 219–223

    PubMed  Google Scholar 

  7. Crum CP, Ikenberg H, Richart RM, Gissman L (1984) Human papillomavirus type and early cervical neoplasia. N Engl J Med 310: 880–883

    PubMed  Google Scholar 

  8. De Villiers E-M, Weidauer H, Otto H, Zur Hausen H (1985) Papillomavirus DNA in human tongue carcinomas. Int J Cancer 36: 575–578

    PubMed  Google Scholar 

  9. Dillner J, Dillner L, Robb J, Willems J, Jones I, Lancaster W, Smith R, Lerner R (1989) A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci USA 86: 3838–3841

    PubMed  Google Scholar 

  10. Dillner J, Dillner L, Utter G, Eklund C, Rotola A, Costa S, Diluca D (1990) Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames. Int J Cancer 45: 529–535

    PubMed  Google Scholar 

  11. Dillner L, Bekassy Z, Jonsson N, Moreno-Lopez J, Blomberg J (1989) Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. Int J Cancer 43: 36–40

    PubMed  Google Scholar 

  12. Durst M, Gissman L, Ikenberg H and Zur Hausen H (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80: 3812–3815

    PubMed  Google Scholar 

  13. Eisen HN (1990) Immunoglobulins and immunoglobulin genes. In: Eisen HN (ed) General immunology. Lippincott, Philadelphia, p 78

    Google Scholar 

  14. Firzlaff JM, Kiviat NB, Beckmann AM, Jenison SA, Galloway DA (1988) Detection of human papillomavirus capsid antigens in various squamous epithelial lesions using antibodies directed against the L1 and L2 open reading frames. Virology 164: 467–477

    PubMed  Google Scholar 

  15. Gissman L, Wolnick L, Ikenberg H, Koldovsky U, Schnurch HG, Zur Hausen H (1983) Human papillomavirus type 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 80: 560–563

    PubMed  Google Scholar 

  16. Hart DNJ, Fabre JW (1981) Demonstration and characterization of Ia-positive dandritic cells in the interstitial connective tissue of rat heart and other tissues, but not brain. J Exp Med 153: 347–361

    Google Scholar 

  17. Head JR and Billingham RE (1986) Concerning the immunology of the uterus. Am J Reprod Immunol 10: 76–81

    Google Scholar 

  18. Reference deleted

  19. Jenison SA, Yu X-P, Valentine JM, Koutsky LA, Christeansen AE, Beckmann AM, Galloway DA (1990) Evidence of prevalent genitaltype human papillomavirus infections in adults and children. J Infect Dis 162: 60–69

    PubMed  Google Scholar 

  20. Kutteh WH, Hatch KD, Blackwell RE, Mestecky J (1988) Secretory immune system of the female reproductive tract: I. Immunoglobulin and secretory component-containing cells. Obstet Gynecol 71: 56–60

    PubMed  Google Scholar 

  21. Lentinen M, Parkkonen P, Luoto H, Yla-outin A, Romppanaen U, Rantala I, Paavanen J (1990) Anti-peptide IgA antibody to a human papillomavirus type 16 E2 — derived synthetic peptide prediat the natural history of cervical HPV infection. In: Monsonego J (ed) Seron symposia 18. Ravin Press, New York, p 509

    Google Scholar 

  22. Lorincz AT, Temple GF, Patterson JA, et al. (1986) Correlation of cellular atypia and human papillomavirus DNA sequences in exfoliated cells of the uterine cervix. Obstet Gynecol 68: 508–512

    PubMed  Google Scholar 

  23. Mayer L, Shlien R (1987) Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med 166: 1471–1483

    PubMed  Google Scholar 

  24. McDermott MR, Smiley JR, Leslie P, Brais J, Rudzroga HE, Bienstock J (1984) Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J Virol 51: 747–753

    PubMed  Google Scholar 

  25. McDonnell JM, Mayr AJ, Martin WJ (1989) DNA of human papillomavirus type 16 in dysplastic and malignant lesions of the conjunctiva and cornea. N Engl J Med 320: 1442–1446

    PubMed  Google Scholar 

  26. Merriman H, Woods S, Winter C, Fahnlander A, Corey C (1984) Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus. J Infect Dis 149: 505–510

    PubMed  Google Scholar 

  27. Moy RL, Elierzri YD, Nuovo GJ, Zitelli JA, Bennett RG, Silverstein SJ (1989) Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA 261: 2669–2673

    PubMed  Google Scholar 

  28. Murdoch AJM, Buckley CH, Fox H (1982) Hormonal control of the secretory immune system of the human cervix. J Reprod Immunol 4: 23–30

    PubMed  Google Scholar 

  29. Nuovo GJ, Pedemonte BM (1990) Human papillomavirus types and recurrent cervical warts. JAMA 263: 1223–1226

    PubMed  Google Scholar 

  30. Nuovo GH, Darfler MM, Impraim CC, Bromley SE (1991) Occurrence of multiple types of human papillomavirus in genital tract lesions: analysis by in-situ hybridization and the polymerase chain reaction. Am J Path 138: 53–58

    PubMed  Google Scholar 

  31. Ogra PL, Ogra SS (1973) Local antibody response to poliovaccine in the human female genital tract. J Immunol 110: 1307–1311

    PubMed  Google Scholar 

  32. Ogra PL, Yamanaka T, Losonsky GA (1981) Local immunologic defenses in the genital tract. Reprod Immunol 381–394

  33. O'Reilly RJ, Lee L, Welch BG (1976) Secretory IgA antibody responses toneisseria gonorrhoeae in the genital secretions of infected females. J Infect Dis 133: 113–125

    PubMed  Google Scholar 

  34. Richart RM, Townsend DE, Crisp W, et al. (1980) An analysis of “long term” follow up results in patients with cervical intraepithelial neoplasia treated by cryotherapy. Am J Obstet Gynecol 137: 823

    PubMed  Google Scholar 

  35. Roncalli M, Sideri M, Paolo G, Servida E (1988) Immunophenotypic analysis of the transformation zone of human cervix. Lab Invest 58: 141–149

    PubMed  Google Scholar 

  36. Schumacher GFB, Kim MH, Hosseinian AH, Dupon C (1977) Immunoglobulins, proteinase inhibitors, albumin, and lysozyme in human cervical mucus. Am J Obstet Gynecol 129: 624–635

    Google Scholar 

  37. Smotkin D, Gerek JS, Fu YS, Hacker NF, Major FJ, Wettstein FO (1986) Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol 68: 241–244

    PubMed  Google Scholar 

  38. Barber S, Snyder R, Crum C, Roche J (1990) Binding by immunoglobulin in cervical secretions to purified macromolecules E4, E1 and L1 coded by the human papillomavirus 16 genome. FASEB 4: 2906

    Google Scholar 

  39. Stoler MH, Walker AN, Mills SE (1989) Small cell neuroendocrine carcinoma of the cervix: a human papillomavirus type 18 associated cervical cancer. Lab Invest 60: 92A

  40. Wira CR, Sandoe CP (1986) In: Mestercky J (ed) Origin of IgA and IgG antibodies in the female reproductive tract: regulation of the genital response by estradiol. Recent advances in mucosal immunology: part I. Cellular interactions. Plenum Press, New York, pp 403

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pathology, Microbiology, Obstetrics and Gynecology and Internal Medicine, University of Virginia Health Sciences Center, MR-4 Building, Box 1002, 22 908, Charlottesville, Virginia, USA

    James K. Roche & Christopher P. Crum

Authors
  1. James K. Roche
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher P. Crum
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roche, J.K., Crum, C.P. Local immunity and the uterine cervix: Implications for cancer-associated viruses. Cancer Immunol Immunother 33, 203–209 (1991). https://doi.org/10.1007/BF01744938

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01744938

Key words

Search

Navigation